Teicoplanin Chemistry and Microbiology

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Glycopeptide resistance is an increasing concern in treating Gram-positive bacterial infections.
• Teicoplanin is a glycopeptide antibiotic with a spectrum of activity against Gram-positive pathogens.

Purpose of the Study:

• To detail the chemistry, microbiology, and mode of action of teicoplanin.
• To discuss the mechanisms, control, and epidemiology of glycopeptide resistance.
• To evaluate teicoplanin's efficacy against various Gram-positive bacteria, including resistant strains.

Main Methods:

• Review of teicoplanin's properties and antibacterial activity.
• Analysis of glycopeptide resistance mechanisms (VanA, VanB, VanC).
• Assessment of teicoplanin's effectiveness against resistant bacterial strains, including Staphylococcus and Enterococcus species.

Main Results:

• Teicoplanin exhibits potent activity against Gram-positive bacteria, comparable to vancomycin but often more effective, especially against Streptococcus and Enterococcus species.
• Some coagulase-negative Staphylococcus strains, particularly S. haemolytieus, show reduced susceptibility to teicoplanin compared to vancomycin.
• Teicoplanin is active against vancomycin resistance mediated by VanB and VanC, but not against VanA-resistant strains.
• The epidemiology of vancomycin-intermediate (VISA) and vancomycin-resistant (GISA) Staphylococcus aureus strains requires further investigation.

Conclusions:

• Teicoplanin demonstrates significant clinical value and potential in treating severe Gram-positive bacterial infections, including sepsis.
• Understanding glycopeptide resistance mechanisms is crucial for optimizing antibiotic therapy.
• Teicoplanin offers a viable treatment option, particularly against infections caused by susceptible Gram-positive organisms.